Investments in and Advances to Joint Ventures (Tables)

6 Months Ended

Jun. 30, 2021

Equity Method Investments And Joint Ventures [Abstract]

Schedule of Financial Information of Consolidated Joint Ventures

The following represents financial information for consolidated joint ventures included in the consolidated financial statements (in thousands):

	June 30, 2021		December 31, 2020
Current assets	$	263,051	$	292,407
Noncurrent assets		2,641		2,990
Total assets		265,692		295,397
Current liabilities		191,223		201,270
Total liabilities		191,223		201,270
Total joint venture equity	$	74,469	$	94,127

	Three Months Ended				Six Months Ended
	June 30, 2021		June 30, 2020		June 30, 2021		June 30, 2020
Revenue	$	98,245	$	117,889	$	194,869	$	218,167
Costs		87,097		101,935		173,403		199,085
Net income	$	11,148	$	15,954	$	21,466	$	19,082
Net income attributable to noncontrolling interests	$	5,325	$	7,826	$	10,300	$	9,224

Summary of Financial Information for Unconsolidated Joint Ventures

The following represents the financial information of the Company’s unconsolidated joint ventures as presented in their unaudited financial statements (in thousands):

	June 30, 2021		December 31, 2020
Current assets	$	1,042,978	$	774,646
Noncurrent assets		614,916		585,802
Total assets		1,657,894		1,360,448
Current liabilities		805,616		703,287
Noncurrent liabilities		565,249		517,697
Total liabilities		1,370,865		1,220,984
Total joint venture equity	$	287,029	$	139,464
Investments in and advances to unconsolidated joint ventures	$	86,045	$	68,975

	Three Months Ended				Six Months Ended
	June 30, 2021		June 30, 2020		June 30, 2021		June 30, 2020
Revenue	$	736,284	$	238,188	$	972,801	$	691,447
Costs		696,198		223,686		907,045		650,691
Net income	$	40,086	$	14,502	$	65,756	$	40,756
Equity in earnings of unconsolidated joint ventures	$	9,428	$	3,769	$	16,958	$	9,883